Entresto Clinical Trials
Here are the 6 most popular medical studies for entresto
Angiotensin Receptor-Neprilysin Inhibitor
ARNI for Systemic Right Ventricle Heart Failure
Recruiting0 awards8 criteria
Montreal, Quebec
This trial is testing whether a new drug, Sacubitril/Valsartan, is better than placebo at improving exercise capacity and reducing neurohormonal activation in people with moderate to severe RV dysfunction.
Angiotensin Receptor Neprilysin Inhibitor
ARB/NEP Inhibition for Heart Failure
Recruiting2 awardsPhase 4
New Haven, Connecticut
“ I'm currently taking Entresto in combination with Furosemide and Coreg to treat Heart Failure, specifically Cardiomyopathy and CHF, and have recently found myself experiencing symptoms more frequently.”
PatientReceived 1 prior treatment
Angiotensin Receptor Blocker/Neprilysin Inhibitor
ARB/NEP Inhibition for Heart Failure
Recruiting2 awardsPhase 4
Nashville, Tennessee
This trial is testing the hypothesis that the effects of LCZ696 on blood pressure, natriuresis, and diuresis at initiation are due to the inhibition of neprilysin, which degrades endogenous bradykinin. The study will enroll 80 subjects with stable heart failure who will be given LCZ696 50 mg and either the bradykinin B2 receptor antagonist icatibant or placebo vehicle in random order (double-blind).
Popular filter options for entresto trials
Clinical Trials With No Placebo
View 15 medical studies that do not have a placebo group.
Angiotensin Receptor Blocker
Sacubitril-Valsartan + Valsartan for High Blood Pressure
Recruiting1 awardPhase 2 & 3
Birmingham, Alabama
This trial seeks to find a way to lower the risk of cardiovascular events for obese individuals by specifically targeting the natriuretic peptides to control blood pressure.
Angiotensin Receptor Neprilysin Inhibitor
Sacubitril/Valsartan for Heart Failure
Recruiting1 award2 criteria
Toronto, Ontario
The purpose of this study is to compare the changes in B-type Natriuretic Peptide (BNP) and amino-terminal fragment of proBNP (NT-proBNP) in outpatients managed in the heart failure (HF) clinic initiated on the Angiotensin Receptor Neprilysin Inhibitor (Entresto) and directly compare the prognostic values of BNP and NT-proBNP in patients admitted with acute decompensated HF.
View More Entresto Trials
See another 3 many medical studies focused on entresto.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.